The effect of quercetin on adipogenesis, lipolysis, and apoptosis in 3T3‐L1 adipocytes: The role of SIRT1 pathways

Abstract Background Lipotoxicity, caused by adipocyte triglyceride over‐accumulation, contributes to obesity‐related comorbidities such as hypertension, type 2 diabetes, coronary heart disease, respiratory dysfunction, and osteoarthritis. This study focuses on determining how sirtuin‐1 (SIRT‐1) medi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Hasan Maleki (Author), Sara Abdizadeh Javazm (Author), Sanaz Dastghaib (Author), Anahita Panji (Author), Mohammad Hojjati Far (Author), Hajar Mahmoodi (Author), Morvarid Siri (Author), Sayed Mohammad Shafiee (Author)
Format: Book
Published: Wiley, 2024-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ee6370ffaa0c42d29cad9e59b7cade2a
042 |a dc 
100 1 0 |a Mohammad Hasan Maleki  |e author 
700 1 0 |a Sara Abdizadeh Javazm  |e author 
700 1 0 |a Sanaz Dastghaib  |e author 
700 1 0 |a Anahita Panji  |e author 
700 1 0 |a Mohammad Hojjati Far  |e author 
700 1 0 |a Hajar Mahmoodi  |e author 
700 1 0 |a Morvarid Siri  |e author 
700 1 0 |a Sayed Mohammad Shafiee  |e author 
245 0 0 |a The effect of quercetin on adipogenesis, lipolysis, and apoptosis in 3T3‐L1 adipocytes: The role of SIRT1 pathways 
260 |b Wiley,   |c 2024-04-01T00:00:00Z. 
500 |a 2055-2238 
500 |a 10.1002/osp4.752 
520 |a Abstract Background Lipotoxicity, caused by adipocyte triglyceride over‐accumulation, contributes to obesity‐related comorbidities such as hypertension, type 2 diabetes, coronary heart disease, respiratory dysfunction, and osteoarthritis. This study focuses on determining how sirtuin‐1 (SIRT‐1) mediates quercetin's (QCT) effect on 3T3‐L1 adipocytes. Key aspects of this study include preventing adipogenesis, inducing lipolysis, and stimulating adipocyte apoptosis. Methods 3T3‐L1 adipocytes underwent treatment with varying QCT doses, lipopolysaccharide (LPS), and the SIRT‐1 inhibitor EX‐527, followed by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium bromide [MTT] assay for cell viability assessment. Furthermore, quantitative real‐time polymerase chain reaction measured mRNA expression levels of adipogenesis markers (fatty acid synthase [FASN] and peroxisome proliferator‐activated receptor gamma [PPARγ]), lipolysis markers (adipose triglyceride lipase [ATGL] and hormone‐sensitive lipase [HSL]), and apoptosis markers (B‐cell lymphoma2 [Bcl‐2], Bcl‐2 Associated ‐X‐protein [BAX] and Caspase‐3). Results The data showed that LPS + QCT significantly reduced cell viability in a dose‐ and time‐dependent manner, unaffected by LPS + QCT + EX‐527. Treatment with LPS + QCT did not affect FASN and PPARγ expression but significantly increased ATGL and HSL mRNA expression compared with LPS alone. Interestingly, EX‐527 reversed the effects of LPS + QCT on lipogenesis and lipolysis markers completely. QCT enhanced apoptosis in a SIRT‐1 independent pattern. Conclusion The data suggest that QCT suppresses adipogenesis while increasing lipolysis via SIRT‐1. However, QCT's effects on apoptosis appear to be independent of SIRT‐1. These findings provide further evidence for QCT's effects on adipocytes, particularly its interaction with SIRT‐1. 
546 |a EN 
690 |a adipogenesis 
690 |a apoptosis 
690 |a obesity 
690 |a quercetin 
690 |a SIRT‐1 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Obesity Science & Practice, Vol 10, Iss 2, Pp n/a-n/a (2024) 
787 0 |n https://doi.org/10.1002/osp4.752 
787 0 |n https://doaj.org/toc/2055-2238 
856 4 1 |u https://doaj.org/article/ee6370ffaa0c42d29cad9e59b7cade2a  |z Connect to this object online.